David W Vredevoogd
6PUBLICATIONS
17CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Feb 07, 2023
Author Correction: Reversal of pre-existing NGFR-driven tumor and immune therapy resistance.Julia Boshuizen, David W Vredevoogd, Oscar Krijgsman
|Jan 30, 2023
TSC2 regulates tumor susceptibility to TRAIL-mediated T-cell killing by orchestrating mTOR signaling.Chun-Pu Lin, Joleen J H Traets, David W Vredevoogd
|Apr 09, 2022
Ubiquitin ligase STUB1 destabilizes IFNγ-receptor complex to suppress tumor IFNγ signaling.Georgi Apriamashvili, David W Vredevoogd, Oscar Krijgsman
|Jul 07, 2021
Predictive Immune-Checkpoint Blockade Classifiers Identify Tumors Responding to Inhibition of PD-1 and/or CTLA-4.Oscar Krijgsman, Kristel Kemper, Julia Boshuizen
|Aug 10, 2020
Reversal of pre-existing NGFR-driven tumor and immune therapy resistance.Julia Boshuizen, David W Vredevoogd, Oscar Krijgsman
|Jan 16, 2018
Cooperative targeting of melanoma heterogeneity with an AXL antibody-drug conjugate and BRAF/MEK inhibitors.Julia Boshuizen, Louise A Koopman, Oscar Krijgsman
Pageof 1
Frequent Collaborators
6 joint publications
Daniel S Peeper
4 joint publications
Julia Boshuizen
2 joint publications
Mara Parren
2 joint publications
Hugo M Horlings
2 joint publications
Christian U Blank
2 joint publications
Keith T Flaherty
2 joint publications
Genevieve M Boland
2 joint publications
Chun-Pu Lin
1 joint publications
Thomas Kuilman
1 joint publications
Paul W H I Parren
